Beam Therapeutics Inc.

18.48
0.84 (4.79%)
At close: Apr 02, 2025, 3:59 PM
17.15
-7.22%
After-hours: Apr 02, 2025, 07:58 PM EDT

Beam Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
Revenue 63.52M 377.71M 60.92M 51.84M 24K 18K n/a n/a
Cost of Revenue n/a 437.38M 22.58M 16.44M 103.18M 5.41M 650K 11K
Gross Profit 63.52M -59.67M 38.34M 35.4M -103.16M -5.39M -650K -11K
Operating Income -415.57M -176.49M -338.48M -392.46M -132.76M -75.15M -45.74M -7.88M
Interest Income n/a n/a 15.3M 9K 1.57M 2.49M 292K n/a
Pretax Income -376.7M -131.16M -260.18M -370.64M -194.59M -78.33M -116.74M -8M
Net Income -376.74M -132.53M -263.59M -341.36M -256.42M -78.44M -115.26M -8M
Selling & General & Admin 111.53M 116.81M 87.81M 57.22M 29.61M 20.55M 11.87M 2.02M
Research & Development 367.56M 437.38M 311.59M 387.09M 103.18M 54.62M 33.87M 5.86M
Other Expenses n/a n/a n/a n/a n/a -71K -10.04M 378K
Operating Expenses 479.09M 554.19M 399.4M 444.31M 132.78M 75.17M 45.74M 7.88M
Interest Expense n/a n/a 15.3M 9K 1.57M 187K n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 479.09M 554.19M 399.4M 444.31M 132.78M 75.17M 45.74M 7.88M
Income Tax 39K 1.37M 3.41M -29.28M 61.83M 116K -71M 500K
Shares Outstanding (Basic) 82.31M 77.15M 70.02M 64.23M 46.73M 51.34M 35.14M 12.95M
Shares Outstanding (Diluted) 82.31M 77.15M 70.02M 64.23M 46.73M 51.34M 35.14M 12.95M
EPS (Basic) -4.58 -1.72 -3.76 -5.31 -5.49 -1.53 -3.28 -0.62
EPS (Diluted) -4.58 -1.72 -3.76 -5.31 -5.49 -1.53 -3.28 -0.62
EBITDA -415.57M -156.47M -324.33M -392.46M -128.03M -71.65M -45.09M -7.99M
EBIT -415.57M -176.49M -338.48M -370.63M -132.76M -75.15M -45.74M -8M
Depreciation & Amortization n/a 20.01M 22.58M 16.44M 9.47M 5.41M 650K 11K